0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sterile Formulation Development Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-19Q16890
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Sterile Formulation Development Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
BUY CHAPTERS

Global Sterile Formulation Development Market Research Report 2025

Code: QYRE-Auto-19Q16890
Report
May 2025
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sterile Formulation Development Market

The global market for Sterile Formulation Development was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Sterile Formulation Development is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Sterile Formulation Development is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Sterile Formulation Development in Preclinical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Sterile Formulation Development include Dalton Pharma Services, PCI Pharma Services, Bioprocess Online, Farbe Firma, Anglo Bio-Pharma Limited, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions, Ardena, Curida, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Sterile Formulation Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sterile Formulation Development.
The Sterile Formulation Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Sterile Formulation Development market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Sterile Formulation Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Sterile Formulation Development Market Report

Report Metric Details
Report Name Sterile Formulation Development Market
Segment by Type
  • Liquid Dosage Form
  • Lyophilized Dosage Form
  • Frozen Dosage Form
  • Others
Segment by Application
  • Preclinical
  • Clinical
  • Commercial
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Dalton Pharma Services, PCI Pharma Services, Bioprocess Online, Farbe Firma, Anglo Bio-Pharma Limited, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions, Ardena, Curida, Curia Global, Carbogen Amcis, Woodstock Sterile Solutions, Cambrex, Aenova Group, Lonza, Catalent, PPD, Althea, Baxter
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Sterile Formulation Development company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Sterile Formulation Development Market report?

Ans: The main players in the Sterile Formulation Development Market are Dalton Pharma Services, PCI Pharma Services, Bioprocess Online, Farbe Firma, Anglo Bio-Pharma Limited, Thermo Fisher Scientific, Pfizer CentreOne, Piramal Pharma Solutions, Ardena, Curida, Curia Global, Carbogen Amcis, Woodstock Sterile Solutions, Cambrex, Aenova Group, Lonza, Catalent, PPD, Althea, Baxter

What are the Application segmentation covered in the Sterile Formulation Development Market report?

Ans: The Applications covered in the Sterile Formulation Development Market report are Preclinical, Clinical, Commercial

What are the Type segmentation covered in the Sterile Formulation Development Market report?

Ans: The Types covered in the Sterile Formulation Development Market report are Liquid Dosage Form, Lyophilized Dosage Form, Frozen Dosage Form, Others

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sterile Formulation Development Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Liquid Dosage Form
1.2.3 Lyophilized Dosage Form
1.2.4 Frozen Dosage Form
1.2.5 Others
1.3 Market by Application
1.3.1 Global Sterile Formulation Development Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Preclinical
1.3.3 Clinical
1.3.4 Commercial
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Sterile Formulation Development Market Perspective (2020-2031)
2.2 Global Sterile Formulation Development Growth Trends by Region
2.2.1 Global Sterile Formulation Development Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Sterile Formulation Development Historic Market Size by Region (2020-2025)
2.2.3 Sterile Formulation Development Forecasted Market Size by Region (2026-2031)
2.3 Sterile Formulation Development Market Dynamics
2.3.1 Sterile Formulation Development Industry Trends
2.3.2 Sterile Formulation Development Market Drivers
2.3.3 Sterile Formulation Development Market Challenges
2.3.4 Sterile Formulation Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sterile Formulation Development Players by Revenue
3.1.1 Global Top Sterile Formulation Development Players by Revenue (2020-2025)
3.1.2 Global Sterile Formulation Development Revenue Market Share by Players (2020-2025)
3.2 Global Sterile Formulation Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Sterile Formulation Development Revenue
3.4 Global Sterile Formulation Development Market Concentration Ratio
3.4.1 Global Sterile Formulation Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sterile Formulation Development Revenue in 2024
3.5 Global Key Players of Sterile Formulation Development Head office and Area Served
3.6 Global Key Players of Sterile Formulation Development, Product and Application
3.7 Global Key Players of Sterile Formulation Development, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Sterile Formulation Development Breakdown Data by Type
4.1 Global Sterile Formulation Development Historic Market Size by Type (2020-2025)
4.2 Global Sterile Formulation Development Forecasted Market Size by Type (2026-2031)
5 Sterile Formulation Development Breakdown Data by Application
5.1 Global Sterile Formulation Development Historic Market Size by Application (2020-2025)
5.2 Global Sterile Formulation Development Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Sterile Formulation Development Market Size (2020-2031)
6.2 North America Sterile Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Sterile Formulation Development Market Size by Country (2020-2025)
6.4 North America Sterile Formulation Development Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Sterile Formulation Development Market Size (2020-2031)
7.2 Europe Sterile Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Sterile Formulation Development Market Size by Country (2020-2025)
7.4 Europe Sterile Formulation Development Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Sterile Formulation Development Market Size (2020-2031)
8.2 Asia-Pacific Sterile Formulation Development Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Sterile Formulation Development Market Size by Region (2020-2025)
8.4 Asia-Pacific Sterile Formulation Development Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Sterile Formulation Development Market Size (2020-2031)
9.2 Latin America Sterile Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Sterile Formulation Development Market Size by Country (2020-2025)
9.4 Latin America Sterile Formulation Development Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sterile Formulation Development Market Size (2020-2031)
10.2 Middle East & Africa Sterile Formulation Development Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Sterile Formulation Development Market Size by Country (2020-2025)
10.4 Middle East & Africa Sterile Formulation Development Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Dalton Pharma Services
11.1.1 Dalton Pharma Services Company Details
11.1.2 Dalton Pharma Services Business Overview
11.1.3 Dalton Pharma Services Sterile Formulation Development Introduction
11.1.4 Dalton Pharma Services Revenue in Sterile Formulation Development Business (2020-2025)
11.1.5 Dalton Pharma Services Recent Development
11.2 PCI Pharma Services
11.2.1 PCI Pharma Services Company Details
11.2.2 PCI Pharma Services Business Overview
11.2.3 PCI Pharma Services Sterile Formulation Development Introduction
11.2.4 PCI Pharma Services Revenue in Sterile Formulation Development Business (2020-2025)
11.2.5 PCI Pharma Services Recent Development
11.3 Bioprocess Online
11.3.1 Bioprocess Online Company Details
11.3.2 Bioprocess Online Business Overview
11.3.3 Bioprocess Online Sterile Formulation Development Introduction
11.3.4 Bioprocess Online Revenue in Sterile Formulation Development Business (2020-2025)
11.3.5 Bioprocess Online Recent Development
11.4 Farbe Firma
11.4.1 Farbe Firma Company Details
11.4.2 Farbe Firma Business Overview
11.4.3 Farbe Firma Sterile Formulation Development Introduction
11.4.4 Farbe Firma Revenue in Sterile Formulation Development Business (2020-2025)
11.4.5 Farbe Firma Recent Development
11.5 Anglo Bio-Pharma Limited
11.5.1 Anglo Bio-Pharma Limited Company Details
11.5.2 Anglo Bio-Pharma Limited Business Overview
11.5.3 Anglo Bio-Pharma Limited Sterile Formulation Development Introduction
11.5.4 Anglo Bio-Pharma Limited Revenue in Sterile Formulation Development Business (2020-2025)
11.5.5 Anglo Bio-Pharma Limited Recent Development
11.6 Thermo Fisher Scientific
11.6.1 Thermo Fisher Scientific Company Details
11.6.2 Thermo Fisher Scientific Business Overview
11.6.3 Thermo Fisher Scientific Sterile Formulation Development Introduction
11.6.4 Thermo Fisher Scientific Revenue in Sterile Formulation Development Business (2020-2025)
11.6.5 Thermo Fisher Scientific Recent Development
11.7 Pfizer CentreOne
11.7.1 Pfizer CentreOne Company Details
11.7.2 Pfizer CentreOne Business Overview
11.7.3 Pfizer CentreOne Sterile Formulation Development Introduction
11.7.4 Pfizer CentreOne Revenue in Sterile Formulation Development Business (2020-2025)
11.7.5 Pfizer CentreOne Recent Development
11.8 Piramal Pharma Solutions
11.8.1 Piramal Pharma Solutions Company Details
11.8.2 Piramal Pharma Solutions Business Overview
11.8.3 Piramal Pharma Solutions Sterile Formulation Development Introduction
11.8.4 Piramal Pharma Solutions Revenue in Sterile Formulation Development Business (2020-2025)
11.8.5 Piramal Pharma Solutions Recent Development
11.9 Ardena
11.9.1 Ardena Company Details
11.9.2 Ardena Business Overview
11.9.3 Ardena Sterile Formulation Development Introduction
11.9.4 Ardena Revenue in Sterile Formulation Development Business (2020-2025)
11.9.5 Ardena Recent Development
11.10 Curida
11.10.1 Curida Company Details
11.10.2 Curida Business Overview
11.10.3 Curida Sterile Formulation Development Introduction
11.10.4 Curida Revenue in Sterile Formulation Development Business (2020-2025)
11.10.5 Curida Recent Development
11.11 Curia Global
11.11.1 Curia Global Company Details
11.11.2 Curia Global Business Overview
11.11.3 Curia Global Sterile Formulation Development Introduction
11.11.4 Curia Global Revenue in Sterile Formulation Development Business (2020-2025)
11.11.5 Curia Global Recent Development
11.12 Carbogen Amcis
11.12.1 Carbogen Amcis Company Details
11.12.2 Carbogen Amcis Business Overview
11.12.3 Carbogen Amcis Sterile Formulation Development Introduction
11.12.4 Carbogen Amcis Revenue in Sterile Formulation Development Business (2020-2025)
11.12.5 Carbogen Amcis Recent Development
11.13 Woodstock Sterile Solutions
11.13.1 Woodstock Sterile Solutions Company Details
11.13.2 Woodstock Sterile Solutions Business Overview
11.13.3 Woodstock Sterile Solutions Sterile Formulation Development Introduction
11.13.4 Woodstock Sterile Solutions Revenue in Sterile Formulation Development Business (2020-2025)
11.13.5 Woodstock Sterile Solutions Recent Development
11.14 Cambrex
11.14.1 Cambrex Company Details
11.14.2 Cambrex Business Overview
11.14.3 Cambrex Sterile Formulation Development Introduction
11.14.4 Cambrex Revenue in Sterile Formulation Development Business (2020-2025)
11.14.5 Cambrex Recent Development
11.15 Aenova Group
11.15.1 Aenova Group Company Details
11.15.2 Aenova Group Business Overview
11.15.3 Aenova Group Sterile Formulation Development Introduction
11.15.4 Aenova Group Revenue in Sterile Formulation Development Business (2020-2025)
11.15.5 Aenova Group Recent Development
11.16 Lonza
11.16.1 Lonza Company Details
11.16.2 Lonza Business Overview
11.16.3 Lonza Sterile Formulation Development Introduction
11.16.4 Lonza Revenue in Sterile Formulation Development Business (2020-2025)
11.16.5 Lonza Recent Development
11.17 Catalent
11.17.1 Catalent Company Details
11.17.2 Catalent Business Overview
11.17.3 Catalent Sterile Formulation Development Introduction
11.17.4 Catalent Revenue in Sterile Formulation Development Business (2020-2025)
11.17.5 Catalent Recent Development
11.18 PPD
11.18.1 PPD Company Details
11.18.2 PPD Business Overview
11.18.3 PPD Sterile Formulation Development Introduction
11.18.4 PPD Revenue in Sterile Formulation Development Business (2020-2025)
11.18.5 PPD Recent Development
11.19 Althea
11.19.1 Althea Company Details
11.19.2 Althea Business Overview
11.19.3 Althea Sterile Formulation Development Introduction
11.19.4 Althea Revenue in Sterile Formulation Development Business (2020-2025)
11.19.5 Althea Recent Development
11.20 Baxter
11.20.1 Baxter Company Details
11.20.2 Baxter Business Overview
11.20.3 Baxter Sterile Formulation Development Introduction
11.20.4 Baxter Revenue in Sterile Formulation Development Business (2020-2025)
11.20.5 Baxter Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Sterile Formulation Development Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Liquid Dosage Form
 Table 3. Key Players of Lyophilized Dosage Form
 Table 4. Key Players of Frozen Dosage Form
 Table 5. Key Players of Others
 Table 6. Global Sterile Formulation Development Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Sterile Formulation Development Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Sterile Formulation Development Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Sterile Formulation Development Market Share by Region (2020-2025)
 Table 10. Global Sterile Formulation Development Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Sterile Formulation Development Market Share by Region (2026-2031)
 Table 12. Sterile Formulation Development Market Trends
 Table 13. Sterile Formulation Development Market Drivers
 Table 14. Sterile Formulation Development Market Challenges
 Table 15. Sterile Formulation Development Market Restraints
 Table 16. Global Sterile Formulation Development Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Sterile Formulation Development Market Share by Players (2020-2025)
 Table 18. Global Top Sterile Formulation Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Formulation Development as of 2024)
 Table 19. Ranking of Global Top Sterile Formulation Development Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Sterile Formulation Development Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Sterile Formulation Development, Headquarters and Area Served
 Table 22. Global Key Players of Sterile Formulation Development, Product and Application
 Table 23. Global Key Players of Sterile Formulation Development, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Sterile Formulation Development Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Sterile Formulation Development Revenue Market Share by Type (2020-2025)
 Table 27. Global Sterile Formulation Development Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Sterile Formulation Development Revenue Market Share by Type (2026-2031)
 Table 29. Global Sterile Formulation Development Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Sterile Formulation Development Revenue Market Share by Application (2020-2025)
 Table 31. Global Sterile Formulation Development Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Sterile Formulation Development Revenue Market Share by Application (2026-2031)
 Table 33. North America Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Sterile Formulation Development Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Sterile Formulation Development Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Sterile Formulation Development Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Sterile Formulation Development Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Sterile Formulation Development Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Sterile Formulation Development Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Sterile Formulation Development Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Sterile Formulation Development Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Sterile Formulation Development Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Sterile Formulation Development Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Sterile Formulation Development Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Sterile Formulation Development Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Dalton Pharma Services Company Details
 Table 49. Dalton Pharma Services Business Overview
 Table 50. Dalton Pharma Services Sterile Formulation Development Product
 Table 51. Dalton Pharma Services Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 52. Dalton Pharma Services Recent Development
 Table 53. PCI Pharma Services Company Details
 Table 54. PCI Pharma Services Business Overview
 Table 55. PCI Pharma Services Sterile Formulation Development Product
 Table 56. PCI Pharma Services Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 57. PCI Pharma Services Recent Development
 Table 58. Bioprocess Online Company Details
 Table 59. Bioprocess Online Business Overview
 Table 60. Bioprocess Online Sterile Formulation Development Product
 Table 61. Bioprocess Online Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 62. Bioprocess Online Recent Development
 Table 63. Farbe Firma Company Details
 Table 64. Farbe Firma Business Overview
 Table 65. Farbe Firma Sterile Formulation Development Product
 Table 66. Farbe Firma Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 67. Farbe Firma Recent Development
 Table 68. Anglo Bio-Pharma Limited Company Details
 Table 69. Anglo Bio-Pharma Limited Business Overview
 Table 70. Anglo Bio-Pharma Limited Sterile Formulation Development Product
 Table 71. Anglo Bio-Pharma Limited Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 72. Anglo Bio-Pharma Limited Recent Development
 Table 73. Thermo Fisher Scientific Company Details
 Table 74. Thermo Fisher Scientific Business Overview
 Table 75. Thermo Fisher Scientific Sterile Formulation Development Product
 Table 76. Thermo Fisher Scientific Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 77. Thermo Fisher Scientific Recent Development
 Table 78. Pfizer CentreOne Company Details
 Table 79. Pfizer CentreOne Business Overview
 Table 80. Pfizer CentreOne Sterile Formulation Development Product
 Table 81. Pfizer CentreOne Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 82. Pfizer CentreOne Recent Development
 Table 83. Piramal Pharma Solutions Company Details
 Table 84. Piramal Pharma Solutions Business Overview
 Table 85. Piramal Pharma Solutions Sterile Formulation Development Product
 Table 86. Piramal Pharma Solutions Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 87. Piramal Pharma Solutions Recent Development
 Table 88. Ardena Company Details
 Table 89. Ardena Business Overview
 Table 90. Ardena Sterile Formulation Development Product
 Table 91. Ardena Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 92. Ardena Recent Development
 Table 93. Curida Company Details
 Table 94. Curida Business Overview
 Table 95. Curida Sterile Formulation Development Product
 Table 96. Curida Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 97. Curida Recent Development
 Table 98. Curia Global Company Details
 Table 99. Curia Global Business Overview
 Table 100. Curia Global Sterile Formulation Development Product
 Table 101. Curia Global Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 102. Curia Global Recent Development
 Table 103. Carbogen Amcis Company Details
 Table 104. Carbogen Amcis Business Overview
 Table 105. Carbogen Amcis Sterile Formulation Development Product
 Table 106. Carbogen Amcis Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 107. Carbogen Amcis Recent Development
 Table 108. Woodstock Sterile Solutions Company Details
 Table 109. Woodstock Sterile Solutions Business Overview
 Table 110. Woodstock Sterile Solutions Sterile Formulation Development Product
 Table 111. Woodstock Sterile Solutions Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 112. Woodstock Sterile Solutions Recent Development
 Table 113. Cambrex Company Details
 Table 114. Cambrex Business Overview
 Table 115. Cambrex Sterile Formulation Development Product
 Table 116. Cambrex Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 117. Cambrex Recent Development
 Table 118. Aenova Group Company Details
 Table 119. Aenova Group Business Overview
 Table 120. Aenova Group Sterile Formulation Development Product
 Table 121. Aenova Group Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 122. Aenova Group Recent Development
 Table 123. Lonza Company Details
 Table 124. Lonza Business Overview
 Table 125. Lonza Sterile Formulation Development Product
 Table 126. Lonza Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 127. Lonza Recent Development
 Table 128. Catalent Company Details
 Table 129. Catalent Business Overview
 Table 130. Catalent Sterile Formulation Development Product
 Table 131. Catalent Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 132. Catalent Recent Development
 Table 133. PPD Company Details
 Table 134. PPD Business Overview
 Table 135. PPD Sterile Formulation Development Product
 Table 136. PPD Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 137. PPD Recent Development
 Table 138. Althea Company Details
 Table 139. Althea Business Overview
 Table 140. Althea Sterile Formulation Development Product
 Table 141. Althea Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 142. Althea Recent Development
 Table 143. Baxter Company Details
 Table 144. Baxter Business Overview
 Table 145. Baxter Sterile Formulation Development Product
 Table 146. Baxter Revenue in Sterile Formulation Development Business (2020-2025) & (US$ Million)
 Table 147. Baxter Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Sterile Formulation Development Picture
 Figure 2. Global Sterile Formulation Development Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Sterile Formulation Development Market Share by Type: 2024 VS 2031
 Figure 4. Liquid Dosage Form Features
 Figure 5. Lyophilized Dosage Form Features
 Figure 6. Frozen Dosage Form Features
 Figure 7. Others Features
 Figure 8. Global Sterile Formulation Development Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Sterile Formulation Development Market Share by Application: 2024 VS 2031
 Figure 10. Preclinical Case Studies
 Figure 11. Clinical Case Studies
 Figure 12. Commercial Case Studies
 Figure 13. Sterile Formulation Development Report Years Considered
 Figure 14. Global Sterile Formulation Development Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Sterile Formulation Development Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Sterile Formulation Development Market Share by Region: 2024 VS 2031
 Figure 17. Global Sterile Formulation Development Market Share by Players in 2024
 Figure 18. Global Top Sterile Formulation Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sterile Formulation Development as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Sterile Formulation Development Revenue in 2024
 Figure 20. North America Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Sterile Formulation Development Market Share by Country (2020-2031)
 Figure 22. United States Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Sterile Formulation Development Market Share by Country (2020-2031)
 Figure 26. Germany Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Sterile Formulation Development Market Share by Region (2020-2031)
 Figure 34. China Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Sterile Formulation Development Market Share by Country (2020-2031)
 Figure 42. Mexico Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Sterile Formulation Development Market Share by Country (2020-2031)
 Figure 46. Turkey Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Sterile Formulation Development Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Dalton Pharma Services Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 50. PCI Pharma Services Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 51. Bioprocess Online Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 52. Farbe Firma Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 53. Anglo Bio-Pharma Limited Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 54. Thermo Fisher Scientific Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 55. Pfizer CentreOne Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 56. Piramal Pharma Solutions Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 57. Ardena Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 58. Curida Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 59. Curia Global Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 60. Carbogen Amcis Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 61. Woodstock Sterile Solutions Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 62. Cambrex Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 63. Aenova Group Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 64. Lonza Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 65. Catalent Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 66. PPD Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 67. Althea Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 68. Baxter Revenue Growth Rate in Sterile Formulation Development Business (2020-2025)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SecuX Technology Inc

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart